These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9625578)
21. Metabolic control by sirtuins and other enzymes that sense NAD Anderson KA; Madsen AS; Olsen CA; Hirschey MD Biochim Biophys Acta Bioenerg; 2017 Dec; 1858(12):991-998. PubMed ID: 28947253 [TBL] [Abstract][Full Text] [Related]
22. Flow-injection analysis with electrochemical detection of reduced nicotinamide adenine dinucleotide using 2,6-dichloroindophenol as a redox coupling agent. Tang HT; Hajizadeh K; Halsall HB; Heineman WR Anal Biochem; 1991 Jan; 192(1):243-50. PubMed ID: 2048728 [TBL] [Abstract][Full Text] [Related]
23. Secondary NAD+ deficiency in the inherited defect of glutamine synthetase. Hu L; Ibrahim K; Stucki M; Frapolli M; Shahbeck N; Chaudhry FA; Görg B; Häussinger D; Penberthy WT; Ben-Omran T; Häberle J J Inherit Metab Dis; 2015 Nov; 38(6):1075-83. PubMed ID: 25896882 [TBL] [Abstract][Full Text] [Related]
24. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia. Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115 [TBL] [Abstract][Full Text] [Related]
25. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Morris CR; Suh JH; Hagar W; Larkin S; Bland DA; Steinberg MH; Vichinsky EP; Shigenaga M; Ames B; Kuypers FA; Klings ES Blood; 2008 Jan; 111(1):402-10. PubMed ID: 17848621 [TBL] [Abstract][Full Text] [Related]
26. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. Airhart SE; Shireman LM; Risler LJ; Anderson GD; Nagana Gowda GA; Raftery D; Tian R; Shen DD; O'Brien KD PLoS One; 2017; 12(12):e0186459. PubMed ID: 29211728 [TBL] [Abstract][Full Text] [Related]
27. A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects. Sadaf A; Dong M; Pfeiffer A; Latham T; Kalfa T; Vinks AA; Ware RE; Quinn CT Clin Pharmacokinet; 2024 Mar; 63(3):357-365. PubMed ID: 38401036 [TBL] [Abstract][Full Text] [Related]
28. L-glutamine for sickle cell disease: Knight or pawn? Sadaf A; Quinn CT Exp Biol Med (Maywood); 2020 Jan; 245(2):146-154. PubMed ID: 31985279 [TBL] [Abstract][Full Text] [Related]
29. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. Rank BH; Carlsson J; Hebbel RP J Clin Invest; 1985 May; 75(5):1531-7. PubMed ID: 3998148 [TBL] [Abstract][Full Text] [Related]
30. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Obrosova IG; Stevens MJ Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971 [TBL] [Abstract][Full Text] [Related]
31. NAD/NADH: redox state changes on cat brain cortex during stimulation and hypercapnia. Gyulai L; Dora E; Kovach AG Am J Physiol; 1982 Oct; 243(4):H619-27. PubMed ID: 7124970 [TBL] [Abstract][Full Text] [Related]
32. Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes. Nahavandi M; Tavakkoli F; Millis RM; Wyche MQ; Habib MJ; Tavakoli N Hematology; 2006 Aug; 11(4):291-4. PubMed ID: 17178670 [TBL] [Abstract][Full Text] [Related]
33. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome. Santaella ML; Font I; Disdier OM P R Health Sci J; 2004 Jun; 23(2):89-93. PubMed ID: 15377055 [TBL] [Abstract][Full Text] [Related]
34. Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders. Schiuma G; Lara D; Clement J; Narducci M; Rizzo R Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38366731 [No Abstract] [Full Text] [Related]
35. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia. Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264 [TBL] [Abstract][Full Text] [Related]
36. Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients. Conran N; Oresco-Santos C; Acosta HC; Fattori A; Saad ST; Costa FF Br J Haematol; 2004 Feb; 124(4):547-54. PubMed ID: 14984506 [TBL] [Abstract][Full Text] [Related]
37. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Williamson DH; Lund P; Krebs HA Biochem J; 1967 May; 103(2):514-27. PubMed ID: 4291787 [TBL] [Abstract][Full Text] [Related]
38. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148 [TBL] [Abstract][Full Text] [Related]
39. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. Ballas SK; Marcolina MJ; Dover GJ; Barton FB Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426 [TBL] [Abstract][Full Text] [Related]
40. Single extraction method for the spectrophotometric quantification of oxidized and reduced pyridine nucleotides in erythrocytes. Wagner TC; Scott MD Anal Biochem; 1994 Nov; 222(2):417-26. PubMed ID: 7864367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]